Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.
Villanueva V, Laloyaux C, D'Souza W, Faught E, Klein P, Reuber M, Rosenow F, Salas-Puig J, Insuga VS, Strzelczyk A, Szaflarski JP, Chinn C, Daniels T, Floricel F, Friesen D, Sendersky V, Besson H, Steinhoff BJ. Villanueva V, et al. Among authors: salas puig j. CNS Drugs. 2023 Sep;37(9):819-835. doi: 10.1007/s40263-023-01033-4. Epub 2023 Sep 9. CNS Drugs. 2023. PMID: 37684497 Free PMC article. Review.
Effectiveness and tolerability of brivaracetam in patients with epilepsy stratified by comorbidities and etiology in the real world: 12-month subgroup data from the international EXPERIENCE pooled analysis.
Szaflarski JP, Besson H, D'Souza W, Faught E, Klein P, Reuber M, Rosenow F, Salas-Puig J, Soto Insuga V, Steinhoff BJ, Strzelczyk A, Bourikas D, Daniels T, Floricel F, Friesen D, Laloyaux C, Villanueva V. Szaflarski JP, et al. Among authors: salas puig j. J Neurol. 2024 Mar 4. doi: 10.1007/s00415-024-12253-z. Online ahead of print. J Neurol. 2024. PMID: 38436680
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability.
Abraira L, Salas-Puig J, Quintana M, Seijo-Raposo IM, Santamarina E, Fonseca E, Toledo M. Abraira L, et al. Among authors: salas puig j. Epilepsy Behav Rep. 2021 Nov 14;16:100504. doi: 10.1016/j.ebr.2021.100504. eCollection 2021. Epilepsy Behav Rep. 2021. PMID: 34901817 Free PMC article.
Initiating antiepilepsy treatment: An update of expert consensus in Spain.
Villanueva V, Sánchez-Álvarez JC, Carreño M, Salas-Puig J, Caballero-Martínez F, Gil-Nagel A. Villanueva V, et al. Among authors: salas puig j. Epilepsy Behav. 2021 Jan;114(Pt A):107540. doi: 10.1016/j.yebeh.2020.107540. Epub 2020 Nov 24. Epilepsy Behav. 2021. PMID: 33243687
Tumor-associated status epilepticus: A prospective cohort in a tertiary hospital.
Vilaseca-Jolonch A, Abraira L, Quintana M, Sueiras M, Thonon V, Toledo M, Salas-Puig J, Fonseca E, Cordero E, Martínez-Ricarte F, Santamarina E. Vilaseca-Jolonch A, et al. Among authors: salas puig j. Epilepsy Behav. 2020 Oct;111:107291. doi: 10.1016/j.yebeh.2020.107291. Epub 2020 Jul 20. Epilepsy Behav. 2020. PMID: 32702656
Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.
Toledo M, Mostacci B, Bosak M, Jedrzejzak J, Thomas RH, Salas-Puig J, Biraben A, Schmitz B. Toledo M, et al. Among authors: salas puig j. J Neurol. 2021 Aug;268(8):2735-2748. doi: 10.1007/s00415-020-09809-0. Epub 2020 Apr 1. J Neurol. 2021. PMID: 32239268 Review.
Long-term epilepsy after early post-stroke status epilepticus.
Abraira L, Toledo M, Guzmán L, Sueiras M, Quintana M, Fonseca E, Salas-Puig J, Alvarez-Sabín J, Santamarina E. Abraira L, et al. Among authors: salas puig j. Seizure. 2019 Jul;69:193-197. doi: 10.1016/j.seizure.2019.04.022. Epub 2019 May 1. Seizure. 2019. PMID: 31077960 Free article.
137 results